pyridoxamine has been researched along with Ventricular Dysfunction, Left in 1 studies
Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deluyker, D | 1 |
| Ferferieva, V | 1 |
| Driesen, RB | 1 |
| Verboven, M | 1 |
| Lambrichts, I | 1 |
| Bito, V | 1 |
1 other study available for pyridoxamine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Pyridoxamine improves survival and limits cardiac dysfunction after MI.
Topics: Animals; Echocardiography; Glycation End Products, Advanced; Hemodynamics; Male; Myocardial Infarcti | 2017 |